Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Abbisko Therapeutics Announces China NMPA Acceptance of New Drug Application for Pimicotinib for the Treatment of TGCT
2025-06-10 12:02
High-Trend International Group Appoints Brian B. Su as Independent Director and Chairman of the Compensation Committee
2025-06-10 09:30
NETMARBLE UNVEILS THE SEVEN DEADLY SINS: ORIGIN OPEN-WORLD RPG FOR PLAYSTATION 5, PC AND MOBILE PLATFORMS
2025-06-10 02:00
Eluminex Biosciences Announces Phase 1b Single Ascending Dose Study Results of a Novel Pentavalent Trispecific Fusion Antibody (EB-105) in Patients with Diabetic Macular Edema (DME)
2025-06-10 00:00
VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation - Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.
2025-06-10 00:00
Jackery Presents Latest Sustainable Energy Solutions at AIA25 Expo
2025-06-09 21:30
Generative Video Pioneer Vidu Powers Honor 400 Series & Reimagines Journey to the West to Forge Blueprint for Next-Gen Original AI Studio
2025-06-09 21:17
Nisun International Expands into Edible Oil Trading Sector, Targeting RMB 3 Billion (USD 415 Million) in 2025 Revenue.
2025-06-09 21:15
Webull Appoints Walter Bishop to Board of Directors
2025-06-09 20:45
Mega Matrix and Wardour Studios Partner to Launch AIFLIX for AI-Generated Short Drama
2025-06-09 20:30
Maitong Sunshine and Qiannan Yunxiang Industry Join Hands to Create a Benchmark for Cultural Tourism Integration in the New Era
2025-06-09 20:06
World's First HLA-G Targeted Exosome Therapy for Cancer Enters U.S. Clinical Trials
2025-06-09 20:03
Neowise Biotechnology and BeOne Medicines Enter Licensing Agreement to Advance Development of Next-Generation Cell Therapies
2025-06-09 20:00
LG Innotek Unveils World's First Automotive 5G Broadband Satellite Communication Module
2025-06-09 20:00
Planet Green Advances AI-Powered Early Mental Health Intervention for Youth in Post-Pandemic Canada
2025-06-09 20:00
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
2025-06-09 19:00
Global Times: At Rizhao Port: Small phone screen unlocks code to transform, upgrade China's global trade
2025-06-09 18:22
51Talk Online Education Group Announces First Quarter 2025 Results
2025-06-09 18:00
Acer Reports May Revenues at NT$19.17 Billion, Up 3.1% Month-on-month
2025-06-09 17:29
Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)
2025-06-09 08:15
1
391
392
393
394
395
7219